News
The Neurotech Now panel at DeviceTalks West 2025 will feature leaders from Synchron, Cognito Therapeutics and Subsense.
Cognito to Present Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety and Durability of Treatment Benefits Over 18 Months at CTAD 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback